Alexandra Golant is a Dermatology physician affiliated with Mount Sinai Hospital. OpenAlex indexes 63 publications with 377 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
30 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year202576 payments$193,047openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202581 payments$127,038openpaymentsdata.cms.gov ↗
- Regeneron Healthcare Solutions, Inc.Program year202576 payments$119,223openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
37.5%Interleukin-4 Receptor alpha Antagonist25.3%Dupixent Syringe63%Dupixent Pen37%Part D<11 patientsCorticosteroid5.9%Triamcinolone Acetonide100%Part D≥26 patients+ 2 more classes in this area
Sensory organs
16.8%Corticosteroid16.8%Clobetasol Propionate48%Betamethasone Dipropionate35%Hydrocortisone17%Part D≥28 patientsCancer & immunology
13.3%Calcineurin inhibitor10.8%Tacrolimus100%Part D≥28 patientsRetinoid2.5%Tretinoin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The role and risks of systemic corticosteroids in atopic dermatitis: an expert consensus
Archives of Dermatological Research
2026 - Atopic Dermatitis, Sleep Quality, and Cognitive Difficulties in US Adults: A 2024 NHIS Mediation Analysis
Experimental Dermatology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Daniel J. Drucker
Mount Sinai Hospital
Karyn Goodman, MD
Mount Sinai Hospital
Edward Wolin, MD
Mount Sinai Hospital
Joshua Zeichner, MD
Mount Sinai Hospital
Robert Modlin, MD
University of California, Los Angeles
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Joel Gelfand, MD
University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”